Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial

Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Page now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.
    Difference
    9%
    Check dated 2025-10-05T10:16:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:15:14.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The old revision tag was removed along with the 'Back to Top' element.
    Difference
    0.5%
    Check dated 2025-09-13T17:36:11.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-09-06T15:13:37.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while also removing specific location details such as state, country, and city information.
    Difference
    51%
    Check dated 2025-08-30T11:55:37.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:51:19.000Z thumbnail image

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.